Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 1 May 23 EFFECT Notice of effectiveness
- 28 Apr 23 424B3 Prospectus supplement
- 26 Apr 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 21 Apr 23 S-4/A Registration of securities issued in business combination transactions (amended)
-
13 Apr 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 29 Mar 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 13 Feb 23 S-4 Registration of securities issued in business combination transactions
ELTX similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on Amendment No. 2 to Form S-4 of Angion Biomedica (File no. 333-269741) Corporation of our report dated, March 21, 2023, relating to the consolidated financial statements of Elicio Therapeutics, Inc., which includes an explanatory paragraph relating to the Company’s ability to continue as a going concern, appearing in the Prospectus which is a part of this Registration Statement.
We also consent to the reference to our firm under the heading “Experts” in such Registration Statement.
/s/ BAKER TILLY US, LLP
Tewksbury, Massachusetts
April 13, 2023